Prelude Therapeutics (PRLD)
(Delayed Data from NSDQ)
$5.16 USD
-1.04 (-16.77%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $5.16 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: -- |
9/2024 | $-0.46 | -1.44% |
Earnings Summary
For their last quarter, Prelude Therapeutics (PRLD) reported earnings of -$0.46 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for PRLD's next earnings release expected on November 06, 2024. For the next earning release, we expect the company to report earnings of -$0.46 per share, reflecting a year-over-year decrease of 2.22%.
Earnings History
Price & Consensus
Zacks News for PRLD
All You Need to Know About Prelude Therapeutics Incorporated (PRLD) Rating Upgrade to Buy
PRLD: What are Zacks experts saying now?
Zacks Private Portfolio Services